Introduction
============

The mevalonate kinase (MVK) gene has 10 coding exons and one non-coding exon at chromosome 12q24. The MVK protein is encoded by two transcripts of MVK and is expressed in various tissues, such as the human skin ([@b1-etm-0-0-8569]). MVK catalyzes the phosphorylation of mevalonic acid into 5-phosphomevalonate, and functions downstream of 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase (HMG-CoA) in the mevalonate pathway. The mevalonate pathway provides crucial molecules to cells, and may be an important metabolic pathway in human skin ([@b2-etm-0-0-8569]). Cholesterol, which is essential in the function of skin barrier, derives from mevalonate pathway ([@b3-etm-0-0-8569]) and MVK plays an important role in the synthesis of isoprenoid and cholesterol. Furthermore, the mevalonate pathway was reported to regulate the gene expression of keratin ([@b4-etm-0-0-8569]). MVK mutations were previously identified in disseminated superficial actinic porokeratosis by exome sequencing ([@b5-etm-0-0-8569]). Moreover, MVK plays an important role in regulating calcium-induced keratinocyte differentiation and protecting keratinocytes from apoptosis induced by type A ultraviolet radiation in cultured primary keratinocytes ([@b5-etm-0-0-8569]).

Keratin 1 (KRT1) and involucrin (IVL) are markers of the differentiation of keratinocytes in the spinous layer and granular layer of skin, respectively. Apoptosis and dysregulation of keratinocyte differentiation was reported to be associated with the pathogenesis of porokeratosis ([@b6-etm-0-0-8569]). Prenylation (farnesylation and geranylgeranylation), also known as lipidation, facilitates the attachment of molecules to cell membranes; hydrophobic molecules are added to a chemical compound or protein during prenylation. The inhibition of prenylation by HMG-CoA reductase inhibitors fluvastatin or compactin was shown to decrease the bradykinin-stimulated generation of inositol 1,4,5-triphosphate in human keratinocytes ([@b7-etm-0-0-8569]). However, the role of MVK in the differentiation, apoptosis and prenylation of human keratinocytes requires further investigation.

Short-chain isoprenoids farnesyl pyrophosphate (FPP) and geranylgeranyl pyrophosphate (GGPP) are the intermediate products of the mevalonate pathway; these attach to small G proteins covalently, and serve as molecular switches in many biochemical pathways ([@b8-etm-0-0-8569]). Small G proteins, such as lamin A, HRAS, KRAS, NRAS, Rho E, Rho B, Rho A, Ras-related C3 botulinum toxin substrate 1 (RAC1) and cell division control protein 42 homolog (CDC42), independently hydrolyze guanosine triphosphate (GTP) in cytosol. However, it is unclear whether FPP and GGPP could rescue the downregulation of MVK expression and whether MVK expression affects the processing of small G proteins.

Thus, the present study aimed to investigate the role of interference and overexpression of MVK in the expression of keratin 1 and involucrin, apoptosis, protein prenylation, and the processing of small G proteins.

Materials and methods
=====================

### Cell culture

HaCaT cells (cat. no. C01-BH; Shanghai Novobioscience, Co., Ltd.) were cultured in Dulbecco\'s modified Eagle\'s medium (DMEM) with GlutaMax™, supplemented with 10% fetal bovine serum (FBS), 100 IU/ml penicillin and 100 µg/ml streptomycin (Gibco; Thermo Fisher Scientific, Inc.). Cells were seeded at 1x10^5^ cells/ml, and the medium was changed every other day up to 90% confluency.

### Construction of recombinant plasmids and lentiviral packaging

According to gene information of MVK (NM_000431.3), three-pairs of oligos encoding the target sequence of MVK ([Table I](#tI-etm-0-0-8569){ref-type="table"}) and CDS domain sequences were designed, synthesized and inserted into interference vector PDS019_PL-shRNA and overexpression vector PDS159_pL6.3-CMV-GFPa1-IRES-MCS (Shanghai Novobioscience, Co., Ltd.), respectively. Interference lentiviral vectors (CL926-1-pL-shRNA-HOMO-MVK-348, CL926-2-PL-shRNA-HOMO-MVK-520, and CL926-3-pL-shRNA-HOMO-MVK-1283) and overexpression lentiviral vector (CL927-pL6.3-CMV-GFPa1-IRES-homo-MVK) were produced. The negative control for interference was non-targeting sequence (5\'-GAAACGATATGGGCTGAATAC-3\'), which was inserted into the vector pL-shRNA (Novobio). The negative control for overexpression was an empty vector pL6.3-CMV-GFPa1-IRES-MCS (Novobio). Correct sequences were confirmed by Sanger sequencing. ViraPower™ Lentiviral Packaging Mix (9 µg; Invitrogen; Thermo Fisher Scientific, Inc.) and the recombinant lentiviral vectors (3 µg; Invitrogen; Thermo Fisher Scientific, Inc.) were added into Opti-Minimum Essential Medium (MEM; Gibco; Thermo Fisher Scientific, Inc.) and mixed, respectively. Lipofectamine® 2000 (36 µl; Invitrogen; Thermo Fisher Scientific, Inc.) was mixed with Opti-MEM (1.5 ml), and incubated at room temperature for 5 min. The plasmid solution and diluted Lipofectamine® 2000 were subsequently mixed, and incubated at room temperature for 5 min. The mixture was added into a culture dish with 293T cells (3x10^6^) and cells were cultured for 48 h. Cell supernatant was collected, centrifuged at 1,500 x g for 10 min at room temperature and filtered. The virus solution was then condensed by centrifuging at 50,000 x g for 2 h at 4˚C, and re-suspended in DMEM. Viruses carrying MVK interference (LV542-1, LV542-2 and LV542-3, respectively) and overexpression vectors were derived, respectively. Human keratinocytes HaCaT were transfected with the viruses (multiplicity of transfection, 10) for 48 h, and reverse transcription-quantitative PCR was utilized to detect efficiency of interference and overexpression, respectively.

### RT-qPCR

The expression of MVK, KRT1 and IVL in HaCat cells was detected by RT-qPCR. HaCat human keratinocytes were divided into 5 groups: i) negative control; ii) MVK interference; iii) MVK interference+FPP (1 µM); iv) MVK interference+GGPP (1 µM); v) MVK overexpression. Prior to detecting the expression of KRT1 and IVL by RT-qPCR, HaCat cells were treated with CaCl~2~ (0.5 mM) for 48 h. Total RNA was extracted from cells using TRIzol® reagent (Invitrogen; Thermo Fisher Scientific, Inc.), according to the manufacturer\'s protocol. SuperScript™ First-Strand Synthesis System (cat. no. 11904018; Invitrogen; Thermo Fisher Scientific, Inc.) was used for RT by applying the following temperature protocol: 65˚C for 5 min; 42˚C for 60 min and 70˚C for 15 min. Each reaction mixture contained 0.5 µl random primers (0.2 µg/µl) and 1 µl SuperScript III reverse transcriptase (200 U/µl; Invitrogen; Thermo Fisher Scientific, Inc.). The specific primers used are listed in [Table II](#tII-etm-0-0-8569){ref-type="table"}. PCR was performed using a SYBR RT-qPCR mix kit (cat. no. 4309155; Invitrogen; Thermo Fisher Scientific, Inc.). The PCR conditions were as follows: Initial denaturation at 95˚C for 2 min, followed by 40 cycles of denaturation at 95˚C for 10 sec, annealing at 60˚C for 30 sec and elongation at 70˚C for 45 sec. PCR was performed using a CFX96 Touch™ Real-Time PCR Detection system (Bio-Rad Laboratories, Inc.). Gene expression was determined and normalized to β-actin. The 2^-ΔΔCq^ method was utilized to determine the relative gene expression ([@b9-etm-0-0-8569]).

### Western blot analysis

Protein expression of MVK, keratin 1, involucrin, lamin A, HRAS, KRAS, NRAS, Rho E, Rho B, Rho A, RAC1 and CDC42 in HaCat cells was detected by western blot analysis. Prior to detecting the expression of KRT1 and IVL by western blotting, HaCat cells were treated with CaCl~2~ (0.5 mM) for 48 h. HaCat cells were lysed in lysis buffer (cat. no. P0013; Beyotime Institute of Biotechnology) at 4˚C with inhibitors of phosphatase and protease (cat. no. P1045; Beyotime Institute of Biotechnology). The lysis mixture was centrifuged at 4˚C at 10,000 x g for 10 min, and the supernatant containing cellular proteins was utilized in following experiments. The protein concentration was measured using Bicinchoninic Acid Assay kit (Beyotime Institute of Biotechnology). Proteins were separated by SDS-PAGE on a 10% gel (40 µg per lane; at 120 V). The separated proteins were then transferred to polyvinylidene fluoride membranes (at 100 V for 120 min). The membranes were blocked at room temperature with 5% non-fat milk for 1 h, and incubated with primary antibodies against MVK (1:1,000; cat. no. 12228-1-AP; ProteinTech Group, Inc.), cytokeratin 1 (1:1,000; cat. no. 16848-1-AP; ProteinTech Group, Inc.), involucrin (1:1,000; cat. no. 55328-1-AP; ProteinTech Group, Inc.), lamin A (1:1,000; cat. no. 10298-1-AP; ProteinTech Group, Inc.), HRAS (1:1,000; cat. no. 18295-1-AP; ProteinTech Group, Inc.), Rho E (1:1,000; cat. no. D223036; Sangon Biotech Co., Ltd.), Rho B (1:1,000; cat. no. 14326-1-AP; ProteinTech Group, Inc.), Rho A (1:1,000; cat. no. 10749-1-AP; ProteinTech Group, Inc.), RAC1 (1:1,000; cat. no. 24072-1-AP; ProteinTech Group, Inc.) and CDC42 (1:1,000; cat. no. 10155-1-AP; ProteinTech Group, Inc.) at 4˚C overnight, respectively. Membranes were washed with Tris-buffered saline containing Tween-20 and incubated with horseradish peroxidase-conjugated goat anti-rabbit secondary antibody (1:2,000; cat. no. D110058; Sangon Biotech Co., Ltd.) at room temperature for 1 h. Membranes were incubated in enhanced chemiluminescence solution (cat. no. P0018A; Beyotime Institute of Biotechnology). Images were captured on film (cat. no. FF057, Beyotime Institute of Biotechnology) in the dark. Experiments were repeated three times. Blot images were quantified in greyscale using the Image-Pro Plus software (version 6.0; Media Cybernetics, Inc.).

### Detection of cell apoptosis by flow cytometry

HaCat cells were radiated with UVA for 5 min, and incubated overnight. The apoptosis of HaCat cells was detected with the Annexin V-PE/7-Aminoactinomycin D (7-AAD) apoptosis assay kit (cat. no. 40310ES20; Shanghai Yeasen Biotechnology Co., Ltd.) using flow cytometry. The cells from each group were washed twice with PBS and incubated with trypsin at 37˚C for 1 min. Following digestion, the cell suspension was centrifuged at 400 x g at room temperature for 5 min. The cell pellet was resuspended with PBS and the centrifugation and resuspension steps were repeated twice. The cells were blocked with 2% bovine serum albumin (Sigma-Aldrich; Merck KGaA) for 30 min at room temperature. 7-AAD (5 µl) and Annexin V-PE (1 µl) reagents were added to 100 µl cell suspension, followed by incubation at room temperature for 10 min. Cells were centrifuged at 400 x g at room temperature for 5 min and re-suspended with PBS three times. Cell fluorescence was detected by flow cytometry. Data were acquired on an LSRII flow cytometer (BD Biosciences) and analyzed with FlowJo software (version 10.2.64; FlowJo LLC). Annexin V^+^ cells were calculated in each experimental group. Apoptotic rate was defined as percentage of Annexin V^+^ cells in each group. Experiments were performed for a total of three times.

### Detection of protein prenylation by flow cytometry

The protein prenylation levels of HaCat cells were detected using flow cytometry. The cells from each group were washed with PBS twice and incubated with trypsin at 37˚C for 1 min. Following digestion, the cell suspension was centrifuged at 400 x g at room temperature for 5 min. The cell pellet was resuspended with PBS and the centrifugation and resuspension steps were repeated twice. The cells were blocked at room temperature with 2% bovine serum albumin (Sigma-Aldrich; Merck KGaA) overnight. Anti-farnesylation antibody (1:1,000; cat. no. ab199481; Abcam) was added to 100 µl cell suspension, followed by incubation at room temperature for 2 h. Cells were then incubated with iFluor goat anti-rabbit IgG (H+L) (1:2,000; cat. no. 16803; AAT Bioquest Inc.) at room temperature for 1 h. Cells were centrifuged at 400 x g at room temperature for 5 min and resuspended with PBS three times. Cell fluorescence was then detected by flow cytometry. Data were acquired on an LSRII flow cytometer (BD Biosciences,) and analyzed with FlowJo software. Cells with positive staining were calculated in each experimental group. Experiments were performed for a total of three times.

### Statistical analysis

Statistical data were analyzed by GraphPad Prism version 5.0 software (GraphPad Software, Inc.). The results are presented as mean ± standard deviation (SD). Differences among ≥3 groups were compared by one-way analysis of variance followed by the Bonferroni post-hoc test. P\<0.05 was considered to indicate a statistically significant difference.

Results
=======

### Confirmation of interference and overexpression of MVK in HaCat cells

Following transfection, the mRNA expression of MVK in HaCat cells was significantly decreased in LV542-1 (MVK-348) and LV542-3 (MVK-1283) groups compared with the negative control group (P\<0.05; [Fig. 1](#f1-etm-0-0-8569){ref-type="fig"}). In addition, the mRNA expression of MVK in HaCat cells was markedly increased in the overexpression group compared with the negative control group (P\<0.001; [Fig. 1A](#f1-etm-0-0-8569){ref-type="fig"}). Although there was no statistical significance in the relative mRNA expression of MVK between LV542-1 and LV542-3 groups, the mean value was lower in LV542-3 group (0.5, LV542-1 group; and 0.49, LV542-3 group). Thus, LV542-3 was used for interference of MVK in subsequent experiments. Moreover, the protein expression of MVK was markedly decreased in the interference groups, and increased in the overexpression group, compared with the negative control groups (P\<0.001 for all groups; [Fig. 1B](#f1-etm-0-0-8569){ref-type="fig"}). These research findings indicate that the interference and overexpression in HaCat cells were successfully induced.

### Decreased expression of keratin 1 and involucrin following MVK interference was markedly attenuated by FPP

Compared with the negative control group, the mRNA and protein expression of keratin 1 and involucrin were significantly decreased following interference of MVK expression (P\<0.01; [Fig. 2](#f2-etm-0-0-8569){ref-type="fig"}). The decrease in the expression of keratin 1 and involucrin following MVK interference was markedly attenuated by FPP (P\<0.01; [Fig. 2](#f2-etm-0-0-8569){ref-type="fig"}). GGPP was not shown to restore the expression of keratin 1 and involucrin following MVK interference. On the other hand, the overexpression of MVK did not alter the expression of keratin 1 and involucrin.

### Increase in apoptotic rate following MVK interference was significantly attenuated by GGPP

The apoptotic rate following MVK interference was markedly increased compared with the negative control group (P\<0.01; [Fig. 3](#f3-etm-0-0-8569){ref-type="fig"}). The increase in apoptotic rate following MVK interference was significantly attenuated by GGPP (P\<0.001; [Fig. 3](#f3-etm-0-0-8569){ref-type="fig"}), but not by FPP. The overexpression of MVK significantly decreased the apoptotic rate of HaCat cells (P\<0.01; [Fig. 3](#f3-etm-0-0-8569){ref-type="fig"}).

### Decrease in protein prenylation levels following MVK interference was markedly attenuated by GGPP

The protein prenylation levels following MVK interference was notably decreased compared with the negative control group (P\<0.01; [Fig. 4](#f4-etm-0-0-8569){ref-type="fig"}). The decrease in prenylation levels following MVK interference was notably attenuated by GGPP (P\<0.05; [Fig. 4](#f4-etm-0-0-8569){ref-type="fig"}), but not by FPP. The overexpression of MVK significantly increased the prenylation levels of HaCat cells (P\<0.001; [Fig. 4](#f4-etm-0-0-8569){ref-type="fig"}).

### FPP or GGPP reversed MVK interference-induced decrease in geranylgeranylation levels of small G proteins

To examine the geranylgeranylation levels of small G proteins in HaCat cells following interference of MVK, the presence of processed (geranylated) and unprocessed (not geranylated) forms of proteins were evaluated ([@b10-etm-0-0-8569]). Geranylated lamin A, HRAS, KRAS, NRAS, Rho E, Rho B, Rho A, RAC1 and cdc42 decreased in HaCat cells following the interference of MVK ([Fig. 5](#f5-etm-0-0-8569){ref-type="fig"}). Furthermore, FPP reversed MVK interference-induced decrease in geranylgeranylation levels of Lamin A, HRAS and Rho E. In addition, GGPP reversed MVK interference-induced decrease in geranylgeranylation levels of Rho A, RAC1 and cdc42. Both FPP and GGPP reversed MVK interference-induced decrease in geranylgeranylation levels of KRAS, NRAS and Rho B ([Fig. 5](#f5-etm-0-0-8569){ref-type="fig"}). Moreover, the overexpression of MVK increased the geranylgeranylation levels of Lamin A, HRAS, KRAS, NRAS, Rho E, Rho B, Rho A, RAC1 and cdc42 ([Fig. 5](#f5-etm-0-0-8569){ref-type="fig"}).

Discussion
==========

The present study demonstrated the decreased expression of keratin 1 and involucrin, following MVK interference, to be notably attenuated by FPP. In addition, the increase in apoptosis and decrease in protein prenylation following MVK interference was significantly attenuated by GGPP. The overexpression of MVK significantly decreased the apoptotic rate and increased prenylation levels. The decrease in geranylgeranylation levels of Lamin A, HRAS, KRAS, NRAS, Rho E, Rho B, Rho A, RAC1 and cdc42 was attenuated by FPP or GGPP.

The decrease in expression of keratin 1 and involucrin following MVK interference was notably attenuated by FPP. The modulation of keratin 1 and involucrin expression was shown to involved in the response of human keratinocytes to ultraviolet radiation ([@b11-etm-0-0-8569]). Keratin and involucrin were expressed in skin diseases such as discoid lupus erythematosus and lichen planus ([@b12-etm-0-0-8569]). High-cell-density phorbol ester and retinoic acid upregulated involucrin in autocrine cultures of human epidermal keratinocytes ([@b13-etm-0-0-8569]). Keratin and involucrin were expressed in keratoacanthoma, which might aid in diagnosis ([@b14-etm-0-0-8569]). The knockdown of protein kinase D1 in normal human epidermal keratinocytes also increased the mRNA expression of involucrin ([@b15-etm-0-0-8569]). In addition, FPP was shown to be the skin metabolite that regulated epidermal responses to inflammation, oxidative stress and migration. The cytoprotective transcriptional factor Nrf2 and its target genes were induced by increased levels of FPP. FPP also functioned as a ligand for glucocorticoid receptor (GR), which is a major regulator of epidermal homeostasis. Comparative microarray analyses demonstrated significant but incomplete overlap between glucocorticoid and FPP regulated genes ([@b16-etm-0-0-8569]). These findings suggest that FPP might have wider transcriptional impact. It is likely that FPP has transcriptional impact on the expression of differentiation markers in keratinocytes, such as keratin 1 and involucrin. The aforementioned effects of FPP were not seen in GGPP, which might explain why the expression of keratin 1 and involucrin following MVK interference was not restored by GGPP. Studies on the effect of MVK on the differentiation of keratinocytes are scarce. The present study indicates that MVK is essential in keratinocyte differentiation.

In addition, the increase in apoptosis following MVK interference was significantly attenuated by GGPP, whereas the overexpression of MVK significantly decreased the apoptotic rate of human keratinocytes. Autophagy impairment, apoptosis, and lack of prenylated proteins were observed in SH-SY5Y neuronal cell model of MVK deficiency ([@b17-etm-0-0-8569]). In addition, MVK mutation and deficiency were shown to cause a rare autosomal recessive disease called mevalonic aciduria. Patients with mevalonic aciduria had recurrent fever episodes with severe neurologic impairments or death in early childhood. The neurodegeneration in patients with mevalonic aciduria might be associated with both the mitochondria-mediated intrinsic apoptosis pathway (caspase 9 and 3) and pyroptosis (caspase 1) ([@b18-etm-0-0-8569]). In addition, statins were reported to induce apoptosis in glioblastoma when the biosynthesis of GGPP was inhibited and consequently decreased levels of Akt and phosphorylated extracellular signal-regulated kinase 1/2 (ERK1/2) ([@b19-etm-0-0-8569]). Therefore, GGPP might inhibit apoptosis by modulating Akt and ERK. The aforementioned effect of GGPP was not evident in FPP, which may explain the reason for the increase in apoptotic rate following MVK interference not being significantly attenuated by FPP. Further investigation is required to elucidate the detailed molecular mechanisms.

The present study revealed decreased protein prenylation level following MVK interference to be significantly attenuated by GGPP. The overexpression of MVK significantly increased the prenylation levels in human keratinocytes. Mutations in MVK were reported to result in temperature-induced defect in the prenylation of small G proteins in lymphoblast cell lines ([@b20-etm-0-0-8569]). Furthermore, defective protein prenylation was shown to be a diagnostic biomarker of MVK deficiency ([@b21-etm-0-0-8569]). Moreover, thienopyrimidine-based bisphosphonate inhibitors of GGPP were shown to block protein prenylation and subsequently lead to cellular apoptosis in multiple myeloma cells ([@b22-etm-0-0-8569]). Hence, the decrease in protein prenylation might be another explanation for the increase in apoptosis following MVK interference.

The decrease in geranylgeranylation levels of small G proteins, such as lamin A, HRAS, Rho E, Rho B, Rho A, RAC1 and cdc42, was attenuated by FPP or GGPP in keratinocytes. The geranygeranylation of small G proteins is involved in various biological processes. HMG-CoA reductase inhibitors were shown to block the activation of calcium-dependent tyrosine kinase Pyk2 by geranylgeranylation of small G protein Rap1 in vascular endothelial cells ([@b23-etm-0-0-8569]). The inhibition of geranylgeranylation was also reported to decrease angiotensin II-mediated free radical production in vascular smooth muscle cells, and small G protein Rac1 was involved in this process ([@b24-etm-0-0-8569]). In addition, geranylgeranylation determined the Rho migratory function in T cells ([@b25-etm-0-0-8569]). Transendothelial migration and invasion of human breast cancer cells were inhibited through prevention of geranylgeranylation of Rho ([@b26-etm-0-0-8569]). Moreover, GGPP-mediated protein geranylgeranylation was important for establishment of communication between oocyte and granulose cells, and transition from primary to secondary follicle in mouse ovary ([@b27-etm-0-0-8569]). GGPP-dependent plasma membrane localization of the small G protein RhoA was shown to be required for RhoA-mediated oncogenic signaling ([@b28-etm-0-0-8569]). Geranylgeranyl and farnesyl groups were attached to C termini of eukaryotic cell proteins by protein geranylgeranyltransferase-I (PGGT-I) and protein farnesyltransferase (PFT), respectively. Both geranylgeranyl and farnesyl groups from GGPP and FPP were transferred to their peptide or protein prenyl acceptor substrates by PGGT-I and PFT ([@b29-etm-0-0-8569]). It is likely that geranylgeranyl groups from GGPP and FPP were transferred to prenyl acceptor substrates of Lamin A, HRAS, Rho E, Rho B, Rho A, RAC1 and cdc42 by PGGT-I and PFT in keratinocytes. The present study revealed for the first time that FPP or GGPP attenuated the decrease in geranylgeranylation of small G proteins in human keratinocytes.

In conclusion, the present study demonstrated that the decrease in expression of keratin 1 and involucrin following MVK interference was notably attenuated by FPP. In addition, the increase in apoptosis and decrease in protein prenylation following MVK interference was significantly attenuated by GGPP. The decrease in geranylgeranylation levels of lamin A, HRAS, KRAS, NRAS, Rho E, Rho B, Rho A, RAC1 and cdc42 was attenuated by FPP or GGPP. Mutations in MVK may interrupt the biological function of keratinocytes and cause disseminated superficial actinic porokeratosis, by affecting protein prenylation in mevalonate pathway and small G proteins. Although further investigation is required to shine light on the molecular mechanisms, the present study might pave the foundation for future therapeutic strategies for diseases with MVK mutation, such as disseminated superficial actinic porokeratosis.
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![Interference and overexpression of MVK. (A) mRNA expression and (B) protein expression of MVK in HaCat human keratinocytes transfected with viruses carrying MVK interference and overexpression vectors, respectively. Relative mRNA expression of MVK was detected by RT-qPCR. The mRNA expression of MVK in HaCat cells was significantly decreased in LV542-1 and LV542-3 groups, and markedly increased in overexpression group compared with the negative control groups. The protein expression of MVK was markedly decreased in interference groups, and increased in overexpression group compared with the negative control groups. Data presented as mean ± SD, n=3/group. ^\*^P\<0.05 and ^\*\*\*^P\<0.001 vs. negative control groups. MVK, mevalonate kinase; RT-qPCR, reverse transcription-quantitative PCR.](etm-19-04-2861-g00){#f1-etm-0-0-8569}

![The mRNA and protein expression of keratin 1 and involucrin following the interference and overexpression of MVK. (A) The mRNA expression of keratin 1 and involucrin. (B) The protein expression of keratin 1 and involucirn. Relative mRNA and protein expression of keratin 1 and involucrin were detected by RT-qPCR and western blotting, respectively. Compared with the negative control group, the mRNA and protein expression of keratin 1 and involucrin were significantly decreased following interference of MVK expression. The decrease in expression of keratin 1 and involucrin following MVK interference was notably attenuated by FPP. Data presented as mean ± SD, n=3/group. ^\*\*^P\<0.01 and ^\*\*\*^P\<0.001 vs. negative control group. ^\#\#^P\<0.01 and ^\#\#\#^P\<0.001 vs. MVK interference group. KRT1, keratin 1; IVL, involucrin; MVK, mevalonate kinase; RT-qPCR, reverse transcription-quantitative PCR; FPP, farnesyl pyrophosphate.](etm-19-04-2861-g01){#f2-etm-0-0-8569}

![Cell apoptosis following the interference and overexpression of MVK. (A) Representative plot images of flow cytometry. (B) Statistical analysis of apoptotic rates. The apoptotic rates of HaCat cells were examined by flow cytometry; apoptotic cells were Annexin V^+^. The apoptotic rate in MVK interference group was markedly increased compared with the negative control group. The increase in apoptotic rate following MVK interference was significantly attenuated by GGPP. The overexpression of MVK significantly decreased the apoptotic rate of HaCat cells. Data presented as mean ± SD, n=3/group. ^\*\*^P\<0.01 vs. negative control groups. ^\#\#\#^P\<0.001 vs. MVK interference group. (-), interference. (+), overexpression. MVK, mevalonate kinase; GGPP, geranylgeranyl pyrophosphate; 7-AAD, 7-Aminoactinomycin D; FPP, farnesyl pyrophosphate.](etm-19-04-2861-g02){#f3-etm-0-0-8569}

![Protein prenylation levels following the interference and overexpression of MVK. Protein prenylation levels were examined by flow cytometry. The prenylation levels following MVK interference was notably decreased compared with the negative control group. The decrease in prenylation levels following MVK interference was notably attenuated by GGPP. The overexpression of MVK significantly increased prenylation levels of HaCat cells. Data presented as mean ± SD, n=3/group. ^\*\*^P\<0.01 and ^\*\*\*^P\<0.001 vs. negative control groups. ^\#^P\<0.05 vs. MVK interference group. MVK, mevalonate kinase; GGPP, geranylgeranyl pyrophosphate; FPP, farnesyl pyrophosphate.](etm-19-04-2861-g03){#f4-etm-0-0-8569}

![Geranylgeranylation levels of small G proteins following the interference and overexpression of MVK. The geranylgeranylated lamin A, HRAS, KRAS, NRAS, Rho E, Rho B, Rho A, RAC1 and cdc42 decreased in HaCat cells following interference of MVK. FPP reversed MVK interference-induced decrease in geranylgeranylation levels of lamin A, HRAS and Rho E. In addition, GGPP reversed MVK interference-induced decrease in geranylgeranylation levels of Rho A, RAC1 and cdc42. Both FPP and GGPP reversed MVK interference-induced decrease in geranylgeranylation levels of KRAS, NRAS and Rho B. 1, negative control-interference; 2, MVK interference; 3, MVK interference+FPP, 4, MVK interference+GGPP; 5, negative control-overexpression; 6, MVK overexpression. MVK, mevalonate kinase; GGPP, geranylgeranyl pyrophosphate; FPP, farnesyl pyrophosphate.](etm-19-04-2861-g04){#f5-etm-0-0-8569}

###### 

Oligo sequences for interference.

  Oligo                    Sequences (5\' to 3\')
  ------------------------ ----------------------------------------------------
  MVK-348-F                CACCGCTTACCCAACATTGGTATCACGAATGATACCAATGTTGGGTAAGC
  MVK-348-R                AAAAGCTTACCCAACATTGGTATCATTCGTGATACCAATGTTGGGTAAGC
  MVK-520-F                CACCGCTGGCCTTTCTTTACTTATACGAATATAAGTAAAGAAAGGCCAGC
  MVK-520-R                AAAAGCTGGCCTTTCTTTACTTATATTCGTATAAGTAAAGAAAGGCCAGC
  MVK-1283-F               CACCGGCTTTGACTGCTTGGAAACCCGAAGGTTTCCAAGCAGTCAAAGCC
  MVK-1283-R               AAAAGGCTTTGACTGCTTGGAAACCTTCGGGTTTCCAAGCAGTCAAAGCC
  Non-targeting sequence   GAAACGATATGGGCTGAATAC

MVK, mevalonate kinase; F, forward; R, reverse.

###### 

Primers for reverse transcription-quantitative PCR.

  Primers   Sequences (5\' to 3\')
  --------- ------------------------
  MVK-F     TTCCCAGGAGCCATGTTGTC
  MVK-R     CTTGCTCTGAGGTGGGTGTT
  KRT1-F    TGGACAACAACCGCAGTCTC
  KRT1-R    CTCTGGTACAAGGACTCGGC
  IVL-F     TATTTCGGGTCCGCTAGGTG
  IVL-R     TGAGGTTGGGATTGGGGTCA
  Actin-F   AGGGAAATCGTGCGTGAC
  Actin-R   CGCTCATTGCCGATAGTG

MVK, mevalonate kinase; IVL, involucrin; KRT1, keratin 1; F, forward; R, reverse.
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